Take the Quiz
Recovery · Copper Peptide

GHK-Cu (Copper Peptide)

Released: Last reviewed:

GHK-Cu is the tripeptide glycyl-histidyl-lysine bound to copper. Studied for wound healing, skin regeneration, hair growth, and anti-inflammatory effects.

Category: Recovery & Healing Last updated 2026-05-25
GHK-Cu (Copper Peptide) at a glance

GHK-Cu is the tripeptide glycyl-histidyl-lysine bound to copper. Studied for wound healing, skin regeneration, hair growth, and anti-inflammatory effects. Mechanism: Copper-binding tripeptide. Typical route: Subcutaneous or topical. FDA status: Not FDA-approved as a finished drug product. GHK-Cu in topical cosmetic preparations is regulated as a cosmetic ingredient (not a drug). Injectable forms are dispensed by compounding pharmacies.

Drug classCopper-binding tripeptide
Half-life~2 hours (parenteral)
RouteSubcutaneous or topical
Common dosing1-2 mg SC, 2-3x/week
FDA statusNot approved (drug)
Cosmetic statusPermitted ingredient

Mechanism of action

GHK-Cu binds to copper ions to form a complex that promotes collagen and elastin synthesis, activates antioxidant pathways, modulates gene expression toward a younger phenotype (per genomic studies), and supports angiogenesis in wound healing.

Dosing reference

Subcutaneous: 1-2 mg per injection, 1-3 times weekly. Topical formulations: 0.05% to 5% cream, applied once or twice daily. Cosmetic preparations are widely available; injectable forms require a prescription.

Dosing information is provided for educational reference and is not medical advice. Patients should not initiate or modify any peptide regimen without consulting a licensed clinician. See our medical disclaimer.

FDA status & regulatory framework

Not FDA-approved as a finished drug product. GHK-Cu in topical cosmetic preparations is regulated as a cosmetic ingredient (not a drug). Injectable forms are dispensed by compounding pharmacies.

U.S. telehealth providers that work with GHK-Cu (Copper Peptide)

Also covered
88/100May 2026 review (v3.0 rubric); v4.1 re-score pending

Starting at $160/mo. Defy Medical is one of the providers covered in our editorial directory that dispenses or coordinates GHK-Cu (Copper Peptide).

Read review →
Also covered
85/100May 2026 review (v3.0 rubric); v4.1 re-score pending

Starting at $180/mo. Marek Health is one of the providers covered in our editorial directory that dispenses or coordinates GHK-Cu (Copper Peptide).

Read review →
Also covered
70/100May 2026 review (v3.0 rubric); v4.1 re-score pending

Starting at $110/mo. Heally is one of the providers covered in our editorial directory that dispenses or coordinates GHK-Cu (Copper Peptide).

Read review →
Also covered
71/100May 2026 review (v3.0 rubric); v4.1 re-score pending

Starting at $125/mo. PeterMD is one of the providers covered in our editorial directory that dispenses or coordinates GHK-Cu (Copper Peptide).

Read review →

Related recovery peptides

Browse the full Recovery & Healing category →

Frequently asked questions about GHK-Cu (Copper Peptide)

What does GHK-Cu do?

GHK-Cu has been studied for wound healing, skin regeneration, hair growth, and anti-inflammatory applications. The peptide upregulates genes associated with tissue repair and collagen synthesis.

Is topical GHK-Cu effective for anti-aging?

Topical GHK-Cu at 0.1-2% concentrations has reasonable evidence for skin firmness, fine-line reduction, and post-procedure recovery. Cosmetic-grade products do not require a prescription.

References

  1. Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108. PMID: 26236730
  2. Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987. PMID: 29986520

Sources are peer-reviewed where available. PubMed (PMID) links resolve to NCBI's PubMed database. FDA links resolve to the U.S. Food and Drug Administration. Citations were last verified 2026-05-11.

Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: October 15, 2026 · This page is informational and does not constitute medical advice.